Sofinnova Investments Inc. Boosts Holdings in GE HealthCare Technologies Inc. $GEHC

Sofinnova Investments Inc. lifted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 6.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 160,876 shares of the company’s stock after buying an additional 9,791 shares during the period. Sofinnova Investments Inc.’s holdings in GE HealthCare Technologies were worth $13,195,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the business. Vanguard Group Inc. boosted its stake in GE HealthCare Technologies by 0.5% during the 4th quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company’s stock worth $4,287,658,000 after purchasing an additional 267,058 shares during the period. Dodge & Cox lifted its stake in shares of GE HealthCare Technologies by 13.4% in the fourth quarter. Dodge & Cox now owns 31,211,229 shares of the company’s stock valued at $2,559,945,000 after purchasing an additional 3,693,918 shares during the period. Capital Research Global Investors lifted its stake in shares of GE HealthCare Technologies by 1.6% in the fourth quarter. Capital Research Global Investors now owns 25,362,352 shares of the company’s stock valued at $2,080,248,000 after purchasing an additional 389,796 shares during the period. State Street Corp lifted its stake in shares of GE HealthCare Technologies by 2.0% in the fourth quarter. State Street Corp now owns 20,049,677 shares of the company’s stock valued at $1,644,475,000 after purchasing an additional 401,932 shares during the period. Finally, Geode Capital Management LLC lifted its stake in shares of GE HealthCare Technologies by 0.3% in the fourth quarter. Geode Capital Management LLC now owns 12,112,503 shares of the company’s stock valued at $989,673,000 after purchasing an additional 37,159 shares during the period. Institutional investors and hedge funds own 82.06% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have issued reports on GEHC shares. Rothschild & Co Redburn cut their target price on shares of GE HealthCare Technologies from $110.00 to $98.00 in a research report on Thursday, April 30th. Argus lowered their target price on shares of GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating for the company in a report on Tuesday, May 19th. Evercore set a $80.00 target price on shares of GE HealthCare Technologies in a report on Thursday, April 30th. BTIG Research decreased their price objective on shares of GE HealthCare Technologies from $85.00 to $80.00 and set a “buy” rating for the company in a research note on Wednesday, April 29th. Finally, Wells Fargo & Company decreased their price objective on shares of GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating for the company in a research note on Thursday, April 30th. Nine analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $80.21.

GE HealthCare Technologies Trading Down 0.6%

GEHC opened at $64.76 on Tuesday. The stock has a market capitalization of $29.46 billion, a PE ratio of 15.49, a P/E/G ratio of 1.47 and a beta of 0.74. The firm’s fifty day moving average price is $66.21 and its 200 day moving average price is $75.07. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95. GE HealthCare Technologies Inc. has a 12-month low of $58.75 and a 12-month high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.08). The company had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The company’s revenue was up 7.4% on a year-over-year basis. During the same period in the prior year, the company earned $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, research analysts expect that GE HealthCare Technologies Inc. will post 4.89 EPS for the current fiscal year.

Insider Activity

In other GE HealthCare Technologies news, Director Kevin Lobo bought 10,000 shares of the stock in a transaction on Friday, May 22nd. The stock was purchased at an average price of $64.18 per share, for a total transaction of $641,800.00. Following the completion of the purchase, the director directly owned 14,363 shares in the company, valued at approximately $921,817.34. This trade represents a 229.20% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Rodney F. Hochman bought 1,618 shares of the firm’s stock in a transaction on Tuesday, May 12th. The stock was purchased at an average price of $62.03 per share, with a total value of $100,364.54. Following the transaction, the director owned 1,618 shares in the company, valued at $100,364.54. The trade was a ∞ increase in their position. The SEC filing for this purchase provides additional information. Insiders have purchased 21,847 shares of company stock valued at $1,361,355 over the last quarter. 0.36% of the stock is owned by company insiders.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.